Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanqi Yu

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Clinical Epigenetics|February 4, 2022
A novel DNA methylation signature associated with lymph node metastasis status in early gastric cancerShang Chen, Yanqi Yu, Tao Li, et al.
Cancers|April 12, 2022
Minimally Invasive Preclinical Monitoring of the Peritoneal Cavity Tumor MicroenvironmentZachary Spencer Dunn, Yan-Ruide Li, Yanqi Yu, et al.
Genomics|June 13, 2020
Identifying potential DNA methylation markers in early-stage colorectal CancerXiaoyu Zhang, Shenmei Wan, Yanqi Yu, et al.
Clinical Epigenetics|April 27, 2021
A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancerWeimei Ruan, Xu Chen, Ming Huang, et al.
Nature Communications|November 8, 2023
Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineeringDerek Lee, Zachary Spencer Dunn, Wenbin Guo, et al.
Nature Biotechnology|May 14, 2024
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture methodYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Med (New York, N.Y.)|August 13, 2025
Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cellsYan-Ruide Li, Zhe Li, Yichen Zhu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Epigenetics|February 4, 2022
A novel DNA methylation signature associated with lymph node metastasis status in early gastric cancerShang Chen, Yanqi Yu, Tao Li, et al.
Cancers|April 12, 2022
Minimally Invasive Preclinical Monitoring of the Peritoneal Cavity Tumor MicroenvironmentZachary Spencer Dunn, Yan-Ruide Li, Yanqi Yu, et al.
Genomics|June 13, 2020
Identifying potential DNA methylation markers in early-stage colorectal CancerXiaoyu Zhang, Shenmei Wan, Yanqi Yu, et al.
Clinical Epigenetics|April 27, 2021
A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancerWeimei Ruan, Xu Chen, Ming Huang, et al.
Nature Communications|November 8, 2023
Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineeringDerek Lee, Zachary Spencer Dunn, Wenbin Guo, et al.
Nature Biotechnology|May 14, 2024
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture methodYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Med (New York, N.Y.)|August 13, 2025
Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cellsYan-Ruide Li, Zhe Li, Yichen Zhu, et al.
Pageof 3